文献速递临床试验与 GCP真实世界研究与卫生经济

改善乳腺癌以患者为中心的沟通:NCI社区肿瘤研究计划(NCORP)内共享治疗讨论系统(SharES)多水平干预的研究方案(Alliance A231901CD)

Improving patient-centered communication in breast cancer: a study protocol for a multilevel intervention of a shared treatment deliberation system (SharES) within the NCI community oncology research program (NCORP) (Alliance A231901CD).
PubMed 文献 · Trials · 2023-01-06

本研究为NCORP癌症照护提供研究(CCDR)试验,在Alliance附属25个外科实践中招募700例乳腺癌患者(预计600例可评估),采用近极小极大混合阶梯楔形交叉设计,评估患者决策工具(iCanDecide±情感支持模块)与临床医生仪表盘组成的SharES多水平干预对知识、自我效能和癌症担忧的影响。

要点

  • SharES包含患者版决策工具iCanDecide(±情感支持模块)与临床医生仪表盘两个组成部分。
  • 采用近极小极大混合阶梯楔形设计,在六个12周时间段内交叉评估两种干预。
  • 主要结局为知识,关键次要结局为自我效能和癌症担忧,于术后5周通过患者报告评估。

核心结论

  • 研究完成后将更好理解多水平干预对乳腺癌以患者为中心沟通的影响,特别是干预组成部分是否改善知识、自我效能并减少癌症担忧。

研究设计与样本

  • 本研究为NCORP癌症照护提供研究(CCDR)试验,在Alliance for Clinical Trials in Oncology Research Base内实施患者与临床医生两个层面的多水平干预。
  • 设计为近极小极大混合阶梯楔形交叉试验,两种干预在六个12周时间段内交叉评估。
  • 计划从Alliance附属25个外科实践招募共700例乳腺癌患者(失访后预计600例可评估)。
  • 主要结局(知识)和关键次要结局(自我效能和癌症担忧)于术后5周通过患者报告评估,次要结局也在术后5周及注册后9个月的第二份调查中评估。

关键数值与推荐

  • SharES包含两种干预:(1)两个版本的循证患者版乳腺癌治疗决策工具iCanDecide(±情感支持模块);(2)临床医生版仪表盘(Clinician Dashboard),由外科医生/临床医生审阅并总结患者持续需求。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Advances in precision medicine have given oncologists new evaluative tools to better individualize treatments for patients with curable breast cancer. These innovations have revealed a need to improve patient understanding of novel, often complex information related to breast cancer treatment decisions. Ensuring patients have the emotional support to face consequential treatment decisions, as well as the opportunity to engage and discuss with their clinicians, is key to improving patient-centered communication and patient understanding. METHODS/DESIGN: This study will implement a multilevel intervention with patient and clinician components as a NCORP Cancer Care Delivery Research (CCDR) trial within the Alliance for Clinical Trials in Oncology Research Base (Alliance). The two interventions in this study, the Shared Decision Engagement System (SharES), include (1) two versions of an evidence-based patient-facing breast cancer treatment decision tool (iCanDecide +/- an emotional support module) and (2) a clinician-facing dashboard (Clinician Dashboard) that is reviewed by surgeons/clinicians and summarizes ongoing patient needs. The design is a near minimax, hybrid stepped wedge trial of SharES where both interventions are being evaluated in a crossed design over six 12-week time periods. The primary outcome (knowledge) and key secondary outcomes (i.e., self-efficacy and cancer worry) are assessed via patient report at 5 weeks after surgery. Secondary outcomes are also assessed at 5 weeks after surgery, as well as in a second survey 9 months after registration. We anticipate recruiting a total of 700 breast cancer patients (600 evaluable after attrition) from 25 surgical practices affiliated with Alliance. DISCUSSION: Upon study completion, we will have better understanding of the impact of a multilevel intervention on patient-centered communication in breast cancer with a specific focus on whether the intervention components improve knowledge and self-efficacy and reduce cancer worry. TRIAL REGISTRATION: ClinicalTrials.gov NCT04549571 . Registered on 16 September 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Hawley ST, Kidwell K, Zahrieh D, et al. Improving patient-centered communication in breast cancer: a study protocol for a multilevel intervention of a shared treatment deliberation system (SharES) within the NCI community oncology research program (NCORP) (Alliance A231901CD). Trials. 2023. PMID: 36609349. doi:10.1186/s13063-022-07048-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。